Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study.

CONCLUSION: MMF seems to be an efficacious alternative in refractory to standard of care nonrenal manifestations of SLE in the long term, allowing for disease activity control and significant reduction in corticosteroid dose. PMID: 26773121 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26773121?dopt=Abstract

Source: J Rheumatol - January 15, 2016 Category: Rheumatology Authors: Tselios K, Gladman DD, Su J, Urowitz MB Tags: J Rheumatol Source Type: research